Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
OncoMed Pharmaceuticals (NASDAQ:OMED) unveils its next round of earnings Thursday. Get prepared with Benzinga's ultimate preview for OncoMed Pharmaceuticals's Q4 earnings.
Earnings and Revenue
OncoMed Pharmaceuticals EPS loss is expected to be around 34 cents, according to sell-side analysts. Sales will likely be near $5.2 million.
OncoMed Pharmaceuticals' loss in the same period a year ago was 64 cents per share. Quarterly sales came in at $6.21 million. If the company were to match the consensus estimate when it reports Thursday, sales would be down 16.06 percent from the year-ago period.
Here's how the company's reported EPS has stacked up against analyst estimates in the past:
| Quarter | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 |
| EPS Estimate | -0.41 | -0.63 | -0.68 | |
| EPS Actual | -0.28 | -0.4 | -0.61 | -0.64 |
Stock Performance
Over the past 52-week period, shares of OncoMed Pharmaceuticals have declined 67.71 percent. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement
Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. The average rating by analysts on OncoMed Pharmaceuticals stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.
Conference Call
OncoMed's Q4 conference call is scheduled to begin at 4:30 p.m. ET and can be accessed here.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!